How to buy Capricor Therapeutics (4LN2.F) shares. I explain how

capricor therapeuticscapricor therapeutics

Capricor Therapeutics, Inc., a biotechnology company, is focused on the development of cell- and exosome-based transformative therapies for the treatment and prevention of a broad spectrum of diseases. The company’s lead candidate, CAP-1002, an allogeneic cardiac bypass cell therapy, has completed a Phase II clinical trial for the treatment of patients with late-onset Duchenne muscular dystrophy (DMD); CAP-1002, which is in the phase II clinical trial for the treatment of cytokine storm associated with COVID-19; and completed several trials investigating the use of CAP-1002 for the treatment of cardiac conditions, including heart failure and post-myocardial infarction with cardiac dysfunction. It is also developing CAP-2003 which is in preclinical development for the treatment of trauma-related injuries and conditions; and two vaccine candidates, which are in a preclinical scenario for the possibility of preventing COVID-19. Capricor is collaborating with Lonza Houston, Inc. for the development of CAP-1002, its cell therapy candidate for the treatment of DMD and other indications. The company was founded in 2005 and is based in Beverly Hills, California.

Graph and share price of the company Capricor Therapeutics (Frankfurt)

5 d





2 and



Capricor Therapeutics, Inc.




310 358 3200

Basic information

How to buy Capricor Therapeutics (4LN2.F) shares. I explain how

Are you looking for how to acquire Capricor Therapeutics (4LN2.F) shares in Frankfurt safely and through a regulated and quality broker? Does it call your attention to be able to invest your profits per month and obtain interest in the stock market? Today I am going to show you how you can register a debit account , a reliable investment platform and very low commissions, and how you can get your first shares of the company Capricor Therapeutics, Inc. (4LN2.F) (4LN2.F) quickly and simply.

The method is very simple :

  • First, we will register with degiro, an investment platform where we will be able to buy shares of Capricor Therapeutics, Inc. (4LN2.F) (4LN2.F).
  • In 2nd place we will enter funds to carry out the 1st investment in shares.
  • Once we see the funds, we will locate Capricor Therapeutics through its ticker, that is, 4LN2.F.
  • Finally we will only have to indicate the number of shares to buy, purchase value and type of order.

Perhaps this summary has been too essential for you, therefore I am going to show you the purchase process with images:

Tutorial, register an account in DEGIRO

The first step is to sign up for Degiro with this link :

buy shares of Capricor Therapeutics, Inc. (4LN2.F)comprar acciones de Capricor Therapeutics, Inc. (4LN2.F)

It will require an email, a username and a password to access, and then we must continue through the link that they have sent us by email.

Then DeGiro will ask us for the necessary information in order to verify our identity card . We must have on hand the passport, DNI (identity document) or driving document, the mobile or cell phone and the bank account number that we are going to use to make our 1st deposit. If you have no idea what this format is like, you can check this simple step-by-step that we have prepared at .

stock Capricor Therapeuticsstock Capricor Therapeutics

Once our account is validated we will be able to put money from the Deposit/Withdraw tab. We will be able to make a bank transfer that will take more or less one to two days, or make the deposit instantly using Sofort, a completely secure and reliable payment gateway.

transfer money bank Capricor Therapeuticstransferir dinero banco Capricor Therapeutics

How to buy Capricor Therapeutics (4LN2.F) stock through DeGiro

When we already have the money we will be able to get our 1st share. You can use the “Place Order” button at the top right or use the spin finder and type in the ticker. In the following screenshot you will see that I have used the Amazon ticker but you must insert (4LN2.F), the Capricor Therapeutics ticker. As it is an action, we will see that the related results are listed and there we will discover to find Capricor Therapeutics. The essential thing is that the ticker, the name of the action and the market in which it is listed coincide. Amazon is listed on Nasdaq (NDQ) and in your case Capricor Therapeutics, Inc. (4LN2.F) is listed in Frankfurt. This step is essential so do not get confused.

american bag falling Capricor Therapeuticsbolsa americana caindo Capricor Therapeutics

When placing the order we will have to pay close attention to the following . We will have the possibility to carry out a limit or market order. You think you want to get a share of Capricor Therapeutics, but its real price is higher. With this limit order we will enter the value at which we want to execute the acquisition and until there are no shares selling at this price, the purchase of the share will not be executed. With a market order, you will buy the number of shares that we have added to the currently selling price, which is going to be very much in line with the actual trading price.

Stop Limit Sell Order Capricor Therapeutics, Inc. (4LN2.F)orden stop limitada de venta Capricor Therapeutics, Inc. (4LN2.F)

In any case, it is very convenient that you look at the type of numbering: permanent or daily . For example, in Spain, the stock market listing is in the morning until 1:00 p.m., and in the United States it corresponds to the afternoon schedule in Spain. If an order is fixed, it will be kept until the point in which it reaches execution, but if you select the option of «of the day», at the time the session ends, if it is not carried out, it will be deleted from your history in Activity – Orders in Pending status.

Hopefully this detailed text has helped you to buy shares in Capricor Therapeutics. Thank you!

  Company information
  • Capricor Therapeutics, Inc. (4LN2.F) Address: 8840 Wilshire Boulevard
    2nd Floor
    Beverly Hills, CA 90211
    United States
    310 358 3200
    – Website:
  • Ticker: 4LN2.F
  • Industry: Unknown
  • Industry: Biotechnology
  • Number of employees: 26
  • Listed market: Frankfurt

key executives

Name Title Salary exercised Year of birth
Dr. Frank Isaac Litvack FACC, MD Exec. President 120k N/A 1956
Dr. Linda Marban Co-founder, Pres, CEO Director 196.5k N/A 1963
Mr. Anthony J. Bergmann MBA CFO Corp. Treasurer 316.5k N/A 1986
Ms. Karen G. Krasney Exec. VP, Gen. Counsel Sec. 346.75k N/A 1953
Dr. Eduardo Marban Co-founder President of Scientific Advisory Board N/A N/A N/A
Dr. Deborah D. Ascheim Consultant N/A N/A 1965
Catherine Lee Kelleher Consultant N/A N/A N/A

Recent events of :

Recent Events November 12, 2021 Full 10-P Filing: DISPERNO TRIMONTY REPORNOV 09, 2021 FULLING 8-K: Results of Operations and Financial Condition, Financial Statements and ExhibitsSep 24, 2021 Full 8-K Filing: Regulation FD Disclosure, Other Events , Financial Statements and Exhibit 13, 2021 Full 10-P Filing: Tectriz ReportAUG 12, 2021 Full 8-K Filing: Results of Operations and Financial Statement, Financial Statements and Exhibits